Clarifying denominators and statistical reporting in methotrexate maintenance for bullous pemphigoid

Xiao Zhu

doi:10.1093/bjd/ljag335

August 12, 2026British Journal of Dermatology

Clarifying denominators and statistical reporting in methotrexate maintenance for bullous pemphigoid

View at Publisher

Ask AI

Bookmark

Share

Key Points

Clarify and address inconsistencies in denominator selection and statistical reporting methodologies regarding methotrexate maintenance therapy for bullous pemphigoid.
Evaluated statistical reporting frameworks and denominator definitions applied in clinical assessments of methotrexate maintenance for bullous pemphigoid.
Identified critical ambiguities in denominator calculation that impact the interpretation of maintenance therapy outcomes.
Highlighted the necessity of standardized statistical reporting to prevent biased efficacy and safety estimates in bullous pemphigoid management.

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

Methodological commentary highlights discrepancies in denominator reporting for methotrexate in bullous pemphigoid, indicating a need for analytical precision.

Abstract

Xiao Zhu; Clarifying denominators and statistical reporting in methotrexate maintenance for bullous pemphigoid, British Journal of Dermatology, , ljag335,

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Xiao Zhu (2026) studied this question.

synapsesocial.com/papers/6a8019a975c2e31742c85be6 https://doi.org/10.1093/bjd/ljag335

View at Publisher

Ask AI

Bookmark

Share

Clarifying denominators and statistical reporting in methotrexate maintenance for bullous pemphigoid

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Clarifying denominators and statistical reporting in methotrexate maintenance for bullous pemphigoid

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading